Elizabeth Register
About Elizabeth Register
Elizabeth Register is a Director at Bristol Myers Squibb and Novartis, with over two decades of experience in the pharmaceutical industry, specializing in Hematology and Cell Therapy.
Current Role at Bristol Myers Squibb
Elizabeth Register serves as the Director at Bristol Myers Squibb, a role she commenced in August 2021. Her responsibilities include overseeing operations within the regulatory affairs domain, with a specialization in Hematology and Cell Therapy. Bristol Myers Squibb is known for its work in innovative therapies and Elizabeth's expertise contributes significantly to the company's commercial regulatory strategy.
Position at Novartis
Elizabeth Register is also associated with Novartis, where she works in Regulatory Advertising and Promotion in East Hanover, New Jersey. Her work involves ensuring that advertising and promotional activities comply with regulatory standards, a critical aspect within the pharmaceutical industry to maintain ethical marketing practices and safeguard public health.
Previous Experience at AbbVie
Elizabeth Register has significant experience at AbbVie, where she held multiple director-level positions. From 2014 to 2016, she was the Director of Regulatory Affairs, Advertising & Promotions. Subsequently, she became the Director of Global Medical Review in 2016 for a period of 8 months. During her tenure, she was responsible for ensuring compliance with global regulatory standards and enhancing the medical review process for global markets.
Roles at Merck
Elizabeth Register worked at Merck for over a decade in various capacities. From 2008 to 2014, she served as the Associate Director of Global Medical Affairs. Prior to this, she was the Senior Product Scientific Manager from 2002 to 2008 and started her career at Merck as a Microbiologist from 2000 to 2003. Her diverse roles at Merck allowed her to gain comprehensive experience in medical affairs, scientific management, and microbiology.
Specialization in Hematology and Cell Therapy
Elizabeth Register specializes in Hematology and Cell Therapy within the Commercial Regulatory Affairs domain. This specialization involves navigating complex regulatory landscapes to bring innovative cell therapies to market. Her expertise is crucial for maintaining compliance and ensuring that new treatments meet stringent regulatory requirements.